Official Title
Respiratory Immune Responses in Human Influenza Virus Infection Across Age to Understand What Dictates Disease Severity
Brief Summary

The goal of this observational study is to understand immune responses to viral airwayinfection in adults, including the elderly. The main question(s) to answer is/are:Why do some individuals acquire only asymptomatic or mild Influenza A virus (IAV)infection while others become severely ill and even succumb to the same disease?Participants will be asked to donate samples when seeking health care for influenza-likesymptoms or if hospitalized for IAV or SARS-CoV-2. Samples asked for are: - Blood sample by venepuncture - Blood sample by capillary sampling - Nasopharyngeal aspirate - Nasopharyngeal swab - Endotracheal tube aspirate - Nasal swab - Nasal curette - Breath Explor (sampling of expired air)Researchers will compare obtained results with the same type of samples from healthycontrols.

Detailed Description

This observational study will specifically investigate different immunological parameters
in blood and at the site of infection in patients with IAV symptoms or confirmed
infection to understand parameters related to disease course. Blood and airway samples
will be analyzed for immune cell subsets and their functionality, antibodies and other
soluble mediators and linked to clinical data. Immune cells will be analyzed using
multi-color flow cytometry, RNA sequencing, and in vitro functionality assays. Fluids
(plasma, serum, supernatants from airway samples and cell culture supernatants) will be
analyzed using ELISA (and or similar methods), proximity extension assay (Olink), etc.

Enrolling by invitation
Influenza A Infection
Influenza B Virus Infection
SARS CoV 2 Infection
RSV Infection
Eligibility Criteria

Inclusion Criteria Patients:

- Influenza A like symptoms and/or

- Confirmed airway infection

Exclusion Criteria Patients:

- Current malignancies

- Immunosuppressive treatment, not including/except hydrocortisone

Exclusion Criteria Controls:

- Airway infection within the past four weeks

- Ongoing antibiotic treatment

- Immunosuppressive treatment

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Sweden
Locations

Familjeläkarna
Stockholm, Sweden

Haga Närakut
Stockholm, Sweden

Karolinska Universitetssjukhuset
Stockholm, Sweden

Sabbatsbergs sjukhus
Stockholm, Sweden

Södertälje Sjukhus
Södertälje, Sweden

Anna Smed Sörensen, PhD, Principal Investigator
Karolinska Institutet

Karolinska Institutet
NCT Number
Keywords
Influenza A virus (IAV)
Influenza B virus (IBV)
SARS CoV 2
respiratory syncytial virus (RSV)
immunology
age-related differences
MeSH Terms
Infections
Communicable Diseases
Virus Diseases
Influenza, Human
COVID-19
Herpesviridae Infections
Respiratory Syncytial Virus Infections